Innovative Psoriasis Laser Treatment Featured on "The Doctors" TV Show

"The Doctors" TV show has been featuring several popular cosmetic and dermatology procedures over the last year, and recently showcased an innovative laser treatment for psoriasis. Dr. Susan Evans, a Beverly Hills cosmetic physician appeared on the show last week to discuss the benefits of a laser procedure that helps to remove the top layer of skin in the affected area to prompt a healing response.

Ms. Evans pointed out that the many creams and medications for psoriasis are simply too thick to penetrate deep into the skin to cause a reaction. When creams, lotions and topical treatments don’t work, many patients are forced to take medications. However, medications for psoriasis are commonly coupled with unpleasant side effects.

The psoriasis laser treatment is a painless procedure that can be performed on an outpatient basis at the dermatology office. The laser penetrates deep into the layers of skin with psoriasis and triggers the body’s natural healing response. Dr. Evans performed the procedure on her show, and explained that most people feel only a warming sensation during the procedure. The procedure is fast, easy, and can be repeated twice per week for six to twelve weeks. Most people enjoy results that can last between six months to a year.

One of the newest psoriasis laser treatments is the XTRAC Excimer Laser, a laser that delivers light therapy safely and directly into the psoriatic plaques. The procedure is painless and there is no discomfort after the procedure. The XTRAC Excimer Laser is also effective for treating other skin conditions, including atopic eczema. Some insurance providers, such as Aetna, do offer health insurance coverage for psoriasis laser treatments if they are considered medically necessary and the patient has not responded well to treatments such as retinoids, corticosteroids, anthralin or Vitamin D.

Further Reading

  • A new genetic test for psoriatic arthritis is now available in Europe as a CE in vitro diagnostic medical device. DermaGenoma, Inc., a molecular dermatology research and development innovator announced the unveiling of the genetic testing system in late July, 2010 and the device is now available under the European In Vitro Diagnostic Directive.

  • Patients with psoriasis may soon have another option in dermatological care thanks to a new oral treatment that has been developed by VBL Therapeutics. The pharmaceutical company has announced the initiation of a Phase 2 efficacy and safety study for an orally-administered immune response modifier that promises to reduce inflammation in the body that triggers psoriasis.

  • The American Academy of Dermatology (AAD) has released a new set of guidelines for the care and management of the treatment of psoriasis with ultraviolet (UV) light therapy, also known as phototherapy.